Clinical Trials Directory

Trials / Completed

CompletedNCT05537649

Glycemic Responses of an Innovative Oat Porridge

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate whether enzymatic modification of starch in a food product using amylomaltase induces a lower glycemic response in healthy subjects compared to its unmodified counterpart.

Detailed description

A single-blind, randomized, cross-over study design will be applied. During each of the two study visits, healthy participants will consume an oatmeal porridge. One porridge will be treated will amylomaltase to modify the molecular structure of starch while the other porridge will serve as a control (unmodified counterpart). Blood glucose measurements will be taken postprandially at regular time points.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOatmeal porridgeInvestigation of the impact of enzymatic modification of the molecular structure of starch by amylomaltase on the postprandial glycemic responses of an oatmeal porridge.

Timeline

Start date
2021-06-23
Primary completion
2021-10-08
Completion
2021-10-08
First posted
2022-09-13
Last updated
2022-09-13

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05537649. Inclusion in this directory is not an endorsement.

Glycemic Responses of an Innovative Oat Porridge (NCT05537649) · Clinical Trials Directory